New analysis workflow for MALDI imaging mass spectrometry: application to the discovery and identification of potential markers of childhood absence epilepsy.

Childhood absence epilepsy is a prototypic form of generalized nonconvulsive epilepsy characterized by short impairments of consciousness concomitant with synchronous and bilateral spike-and-wave discharges in the electroencephalogram. For scientists in this field, the BS/Orl and BR/Orl mouse lines, derived from a genetic selection, constitute an original mouse model "in mirror" of absence epilepsy. The potential of MALDI imaging mass spectrometry (IMS) for the discovery of potential biomarkers is increasingly recognized. Interestingly, statistical analysis tools specifically adapted to IMS data sets and methods for the identification of detected proteins play an essential role. In this study, a new cross-classification comparative design using a combined discrete wavelet transformation-support vector machine classification was developed to discriminate spectra of brain sections of BS/Orl and BR/Orl mice. Nineteen m/z ratios were thus highlighted as potential markers with very high recognition rates (87-99%). Seven of these potential markers were identified using a top-down approach, in particular a fragment of Synapsin-I. This protein is yet suspected to be involved in epilepsy. Immunohistochemistry and Western Blot experiments confirmed the differential expression of Synapsin-I observed by IMS, thus tending to validate our approach. Functional assays are being performed to confirm the involvement of Synapsin-I in the mechanisms underlying childhood absence epilepsy.

[1]  Pierre Chaurand,et al.  Imaging mass spectrometry of thin tissue sections: a decade of collective efforts. , 2012, Journal of proteomics.

[2]  Wim E Crusio,et al.  Genetic selection of mouse lines differing in sensitivity to a benzodiazepine receptor inverse agonist , 1998, Brain Research.

[3]  J. Goodship,et al.  Identification of a mutation in synapsin I, a synaptic vesicle protein, in a family with epilepsy , 2004, Journal of Medical Genetics.

[4]  J. Blundon,et al.  Impaired Locomotor Learning and Altered Cerebellar Synaptic Plasticity in pep-19/pcp4-Null Mice , 2011, Molecular and Cellular Biology.

[5]  N. Henderson,et al.  Spurious Associations in Unreplicated Selected Lines , 1997, Behavior genetics.

[6]  B. Keppler,et al.  Fragmentation methods on the balance: unambiguous top–down mass spectrometric characterization of oxaliplatin–ubiquitin binding sites , 2012, Analytical and Bioanalytical Chemistry.

[7]  S. Mohammed,et al.  Improved peptide identification by targeted fragmentation using CID, HCD and ETD on an LTQ-Orbitrap Velos. , 2011, Journal of proteome research.

[8]  R. Caprioli,et al.  Identification of proteins directly from tissue: in situ tryptic digestions coupled with imaging mass spectrometry. , 2007, Journal of mass spectrometry : JMS.

[9]  Y. Mechref,et al.  Characterizing protein glycosylation sites through higher-energy C-trap dissociation. , 2010, Rapid communications in mass spectrometry : RCM.

[10]  M. Clench,et al.  Novel molecular tumour classification using MALDI–mass spectrometry imaging of tissue micro-array , 2010, Analytical and bioanalytical chemistry.

[11]  A. Depaulis,et al.  Genetic absence epilepsy in rats from Strasbourg--a review. , 1992, Journal of neural transmission. Supplementum.

[12]  Joonhee Kim,et al.  Proteomic analysis of stargazer mutant mouse neuronal proteins involved in absence seizure , 2008, Journal of neurochemistry.

[13]  Ying S. Ting,et al.  Protein Identification Using Top-Down Spectra* , 2012, Molecular & Cellular Proteomics.

[14]  Bart J. A. Mertens,et al.  Biomarker discovery in MALDI-TOF serum protein profiles using discrete wavelet transformation , 2009, Bioinform..

[15]  Lisa H Cazares,et al.  Imaging Mass Spectrometry of a Specific Fragment of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Kinase 2 Discriminates Cancer from Uninvolved Prostate Tissue , 2009, Clinical Cancer Research.

[16]  Pierre P Massion,et al.  High‐throughput proteomic analysis of formalin‐fixed paraffin‐embedded tissue microarrays using MALDI imaging mass spectrometry , 2008, Proteomics.

[17]  L. Brodin,et al.  Impairment of synaptic vesicle clustering and of synaptic transmission, and increased seizure propensity, in synapsin I-deficient mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  N. Kelleher,et al.  Web and database software for identification of intact proteins using "top down" mass spectrometry. , 2003, Analytical chemistry.

[19]  Jeramie D Watrous,et al.  The evolving field of imaging mass spectrometry and its impact on future biological research. , 2011, Journal of mass spectrometry : JMS.

[20]  Jean-Michel Camadro,et al.  Imaging mass spectrometry provides fingerprints for distinguishing hepatocellular carcinoma from cirrhosis. , 2011, Journal of proteome research.

[21]  A. Ogan,et al.  Changes in intracellular protein expression in cortex, thalamus and hippocampus in a genetic rat model of absence epilepsy , 2011, Brain Research Bulletin.

[22]  N. Kelleher,et al.  Intact mass detection, interpretation, and visualization to automate Top‐Down proteomics on a large scale , 2010, Proteomics.

[23]  Patrick Ducoroy,et al.  Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker. , 2007, Journal of proteome research.

[24]  Tyler A. Zimmerman,et al.  An analytical pipeline for MALDI in-source decay mass spectrometry imaging. , 2011, Analytical chemistry.

[25]  Laurent Mottron,et al.  SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function. , 2011, Human molecular genetics.

[26]  Yong-Bin Kim,et al.  ProSight PTM: an integrated environment for protein identification and characterization by top-down mass spectrometry , 2004, Nucleic Acids Res..

[27]  Richard M Caprioli,et al.  MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives. , 2011, Trends in biotechnology.

[28]  F. Benfenati,et al.  Synaptic and extrasynaptic origin of the excitation/inhibition imbalance in the hippocampus of synapsin I/II/III knockout mice. , 2013, Cerebral cortex.

[29]  Scott M Wilson,et al.  Ubiquitin Homeostasis Is Critical for Synaptic Development and Function , 2011, The Journal of Neuroscience.

[30]  H. Kleinman,et al.  Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications , 2012, Expert opinion on biological therapy.

[31]  S. Rauser,et al.  MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer. , 2011, The American journal of pathology.

[32]  Yong-Bin Kim,et al.  ProSight PTM 2.0: improved protein identification and characterization for top down mass spectrometry , 2007, Nucleic Acids Res..

[33]  Theodore Alexandrov,et al.  On the Importance of Mathematical Methods for Analysis of MALDI-Imaging Mass Spectrometry Data , 2012, J. Integr. Bioinform..

[34]  D. Calligaris,et al.  MALDI in-source decay of high mass protein isoforms: application to alpha- and beta-tubulin variants. , 2010, Analytical chemistry.

[35]  Jonathan Stauber,et al.  Perspectives for imaging mass spectrometry in the proteomics landscape , 2009, Proteomics.

[36]  Michel Salzet,et al.  Multivariate analyses for biomarkers hunting and validation through on-tissue bottom-up or in-source decay in MALDI-MSI: application to prostate cancer , 2011, Analytical and bioanalytical chemistry.

[37]  O. Yalçin.  Genes and molecular mechanisms involved in the epileptogenesis of idiopathic absence epilepsies , 2012, Seizure.

[38]  Loïc Quinton,et al.  MALDI-in source decay applied to mass spectrometry imaging: a new tool for protein identification. , 2010, Analytical chemistry.

[39]  Bernhard Spengler,et al.  Protein identification by accurate mass matrix-assisted laser desorption/ionization imaging of tryptic peptides. , 2011, Rapid communications in mass spectrometry : RCM.

[40]  T. Südhof,et al.  Essential functions of synapsins I and II in synaptic vesicle regulation , 1995, Nature.

[41]  M. Mann,et al.  Higher-energy C-trap dissociation for peptide modification analysis , 2007, Nature Methods.

[42]  Detlev Suckau,et al.  Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry. , 2010, Journal of proteome research.

[43]  F. H. Lopes da Silva,et al.  Evolving concepts on the pathophysiology of absence seizures: the cortical focus theory. , 2005, Archives of neurology.

[44]  Andreas Kowarsch,et al.  Classification of HER2/neu status in gastric cancer using a breast-cancer derived proteome classifier. , 2010, Journal of proteome research.

[45]  F. Yin,et al.  Characterization, using comparative proteomics, of differentially expressed proteins in the hippocampus of the mesial temporal lobe of epileptic rats following treatment with valproate , 2010, Amino Acids.

[46]  U. Argikar,et al.  An experimental approach to enhance precursor ion fragmentation for metabolite identification studies: application of dual collision cells in an orbital trap. , 2011, Rapid communications in mass spectrometry : RCM.

[47]  L. Fricker.  Analysis of mouse brain peptides using mass spectrometry-based peptidomics: implications for novel functions ranging from non-classical neuropeptides to microproteins. , 2010, Molecular bioSystems.

[48]  L. Arckens,et al.  Thymosin beta 4 mRNA and peptide expression in phagocytic cells of different mouse tissues , 2009, Peptides.

[49]  R. Olsen.  Combining Ubiquitin Deficiency and GABA-Mediated Inhibition Equals Seizures? , 2011, Epilepsy currents.

[50]  Michael Becker,et al.  Revisiting Rat Spermatogenesis with MALDI Imaging at 20-μm Resolution* , 2010, Molecular & Cellular Proteomics.

[51]  Kristina Schwamborn,et al.  Molecular imaging by mass spectrometry — looking beyond classical histology , 2010, Nature Reviews Cancer.

[52]  Marisa N. Spann,et al.  Symptoms of anxiety and depression in childhood absence epilepsy , 2011, Epilepsia.

[53]  M. Mann,et al.  Ultra High Resolution Linear Ion Trap Orbitrap Mass Spectrometer (Orbitrap Elite) Facilitates Top Down LC MS/MS and Versatile Peptide Fragmentation Modes* , 2011, Molecular & Cellular Proteomics.

[54]  E. Driggers,et al.  Protein fucosylation regulates synapsin Ia/Ib expression and neuronal morphology in primary hippocampal neurons. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Joonhee Kim,et al.  Proteomic analysis of γ‐butyrolactone‐treated mouse thalamus reveals dysregulated proteins upon absence seizure , 2007, Journal of neurochemistry.

[56]  P. Greengard,et al.  Impairment of axonal development and of synaptogenesis in hippocampal neurons of synapsin I-deficient mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.